126 related articles for article (PubMed ID: 12913995)
1. [Comparative study of lipid lowering effect and influence on platelet aggregation of atorvastatin and simvastatin in patients ischemic heart disease with type II diabetes and combined hyperlipidemia].
Vasiutina EI; Metel'kaya VA; Akhmedzhanov NM; Raszzivin VA; Oganov RG
Kardiologiia; 2003; 43(1):30-5. PubMed ID: 12913995
[No Abstract] [Full Text] [Related]
2. Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin.
Lampl Y; Lorberboym M; Gilad R; Vysberg I; Tikozky A; Sadeh M; Boaz M
Clin Neuropharmacol; 2010 May; 33(3):129-34. PubMed ID: 20502132
[TBL] [Abstract][Full Text] [Related]
3. Did a flawed study design affect the results of the VYTAL study?
McMahon DE
Mayo Clin Proc; 2007 Apr; 82(4):521-2; author reply 522. PubMed ID: 17418081
[No Abstract] [Full Text] [Related]
4. No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.
Singhal MK; Bhaskaran S; Szabo T; La Rosa R
Perit Dial Int; 1999; 19(1):89-91. PubMed ID: 10201354
[No Abstract] [Full Text] [Related]
5. Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes.
Wägner AM; Ordóñez-Llanos J; Jorba O; Pérez A
Metabolism; 2004 Nov; 53(11):1516. PubMed ID: 15558848
[No Abstract] [Full Text] [Related]
6. A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.
Matafome P; Nunes E; Louro T; Amaral C; Crisóstomo J; Rodrigues L; Moedas AR; Monteiro P; Cipriano A; Seiça R
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):241-51. PubMed ID: 18936912
[TBL] [Abstract][Full Text] [Related]
7. [Effect of therapy with atorvastatin on parameters of postprandial lipemia and factors of inflammation in patients with ischemic heart disease].
Samoĭlenko EIu; Naumov VG; Tvorogova MG; Ezhov MV; Sergienko IV; Kukharchuk VV
Kardiologiia; 2007; 47(2):4-8. PubMed ID: 17495815
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin versus simvastatin.
Calder RA
Am J Cardiol; 1997 Dec; 80(12):1646. PubMed ID: 9416964
[No Abstract] [Full Text] [Related]
9. The lipid-regulating effects of atorvastatin on type 2 elder diabetes patients with hyperlipidemia.
Tu L; Liu X; Li R; Huang K; Yao H; Fan Q
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(2):138-9. PubMed ID: 15315163
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
[TBL] [Abstract][Full Text] [Related]
11. Variable influence of statins on isoprostanes in hyperlipidemia.
Sinzinger H; Oguogho A
Adv Exp Med Biol; 2003; 525():209-12. PubMed ID: 12751770
[No Abstract] [Full Text] [Related]
12. Rigorous detection and vigorous treatment of familial hypercholesterolaemia.
Durrington PN
Lancet; 2001 Feb; 357(9256):574-5. PubMed ID: 11558479
[No Abstract] [Full Text] [Related]
13. Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?
Sathyapalan T; Atkin SL; Kilpatrick ES
Diabetes Obes Metab; 2010 Jun; 12(6):540-4. PubMed ID: 20518809
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy--what now?
Drug Ther Bull; 2001 Mar; 39(3):17-21. PubMed ID: 11284361
[TBL] [Abstract][Full Text] [Related]
15. Measurement of atherosclerosis progression.
Young JH
Lancet; 2001 Jul; 358(9278):328-9. PubMed ID: 11501528
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN): response to Knopp.
Gazi IF; Mikhailidis DP
Diabetes Care; 2006 Nov; 29(11):2561; author reply 2561-2. PubMed ID: 17065709
[No Abstract] [Full Text] [Related]
17. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
Yee HS; Fong NT
Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin.
Jacobson TA; Wertz DA; Kuznik A; Cziraky M
Curr Med Res Opin; 2013 Jul; 29(7):773-81. PubMed ID: 23647370
[TBL] [Abstract][Full Text] [Related]
19. A comparative economic analysis of simvastatin versus atorvastatin: results of the Surrogate Marker Cost-Efficacy (SMaC) study.
Arikian S
Clin Ther; 2000 Apr; 22(4):494-6. PubMed ID: 10823368
[No Abstract] [Full Text] [Related]
20. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
